An Opportunity for Employers: Understanding the Future of Cell and Gene Therapy | Sessions

Search Schedule

Concurrent Session
An Opportunity for Employers: Understanding the Future of Cell and Gene Therapy
In-Person and Virtual Monday 06/24/2024 11:00 AM - 12:00 PM   Add to calendar

Competencies: Business (Behavioral), Leadership (Behavioral), Workplace (Technical) | Intended Audience: Mid-Level, Senior-Level, Executive-level

Seating Instructions: Seating is first-come, first-served. Reserved seating options are available for accessibility and accommodations. For detailed accessibility information, visit INFO > FAQs in the app.

In this session, attendees will hear from Jennifer Malinowki, MS, PhD, and Rebecca (Becki) Hulinsky, MS, CGC, as they delve into the transformative potential of Cell and Gene Therapies (CGTs). These therapies are reshaping the healthcare landscape with their targeted approach to treating diseases, improving health outcomes, and in certain cases, offering cures.  The session will highlight the benefits of including CGT coverage in employer health plans. Such inclusion can serve as a significant benefit, attracting and retaining top talent while promoting better health outcomes for employees. CGTs are distinct from traditional therapies as they address diseases at their genetic or cellular level, rather than merely managing symptoms. By modifying a patient's cells or genes, these therapies can potentially cure or significantly alleviate certain conditions, offering hope to patients who were previously without effective treatment options. Of course, the introduction of CGTs into the healthcare landscape is not without its challenges. These primarily revolve around manufacturing complexities and ensuring accessibility for all who could benefit from them. Employers can play a pivotal role in making these innovative therapies more accessible and available. Join us as we delve into the groundbreaking world of CGTs, explore the patient experience, and discuss the essential role of employers in this new healthcare landscape. Learning Objectives:Learn about the crucial role employers can play in making CGTs more accessible and the benefits they stand to gain by including CGT coverage in their health plans.Navigate the patient journey and experience pre- and post-CGT treatment.Gain firsthand insights from Johnson & Johnson and their partner on their experiences and strategies in the CGT landscape.Begin formulating a strategic approach to navigate the complexities of the CGT landscape in your organization. Seating Instructions: Seating is first-come, first-served. Reserved seating options are available for accessibility and accommodations. For detailed accessibility information, visit INFO > FAQs in the app. 

Direct Link to Session Materials: If the speaker provides session materials, you can access them via the app, web format or at https://presentations.shrm.org/.

Live Streaming and Recording: Unless marked 'in person only,' all sessions are live-streamed on the app or web format and available for replay 30 days after the event.

Acknowledgment of Technical Issues: While rare, technical issues may occur during sessions. We appreciate your patience as we quickly address them.

Accessibility & Accommodations Information: For detailed accessibility & accommodations information, visit INFO > FAQs in the app.

Jennifer Malinowski, MS, PhD Photo
Presenter:
Jennifer Malinowski, MS, PhD, Director, Access and Policy Research, Scientific Affairs ,
Johnson & Johnson
Rebecca (Becki)  Hulinsky, MS, CGC Photo
Presenter:
Rebecca (Becki) Hulinsky, MS, CGC, Director, Health Plan Genomics Strategy and Solutions,
Quest Diagnostics
Cheryl Larson Photo
Presenter:
Cheryl Larson, President and CEO ,
Midwest Business Group on Health (MBGH)